Trial Profile
Assessment of Hepatitis B Vaccination Efficacy in Patients With Inflammatory Bowel Diseases.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Apr 2020
Price :
$35
*
At a glance
- Drugs Hepatitis B vaccine recombinant (Primary)
- Indications Hepatitis B
- Focus Pharmacodynamics
- 19 Apr 2020 Status changed from active, no longer recruiting to completed.
- 19 May 2015 Results presented at the Digestive Disease Week 2015.
- 06 Jun 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.